Introduction
candidiasis. Superficial candidiasis is usually treated with a topical preparation such as nystatin or miconazole, while disseminated infections require systemic therapy, e.g., amphotericin B. Amphotericin B, nystatin and miconazole inhibit the growth of many of fungi in vitro. The antifungal activity of these drugs has been reported to be due to an interaction with sterol in the cell membrane of fungus, especially the ergosterol.
[1] The polyene-resistant mutants of C. albicans have a different phospholipid fatty acyl composition.
[2] The differing fatty acid composition has been suggested as a reason for the variation in polyene sensitivity to C. albicans. [3] Azoles interact directly with the membrane lipids without necessarily binding to them. [4, 5] For example, interaction with cell membrane phospholipids and fatty acids causes leakage of proteins and amino acids. [6, 7] Miconazole interacts with phospholipids and changes the lipid organisation without binding to the lipids. [7, 8] inhibitor of fatty acid.
[11] However it has also been shown that fatty acids are capable of protecting Saccharomyces cerevisiae against the action of polyenes.
[12] Palmitoleic acid (C 16:1 ), oleic acid (C 18:1 ), α-linoleic acid (C 18:2 ), γ-linolenic acid (C 18:3 ) and arachidonic acid (C 20:4 ) have been reported to possess an antagonistic effect against clotrimazole and miconazole.
[13]
Moreover, the fatty acid content of the polyene sensitive cultures of C. glabrata differs from the polyene-resistant cultures. [14] The imidazoles, such as miconazole, econazole, clotrimazole and ketoconazole, decrease the unsaturatedsaturated ratio of fatty acids in vivo. [15] Chrysodin has been reported to significantly decrease the percentage composition of linolenic acid and linoleic acid, and to increase that of oleic acid.
[10] The linoleate content in the phospholipid fraction of C. albicans increased from 15% to 25% when incubated in the presence of ketoconazole or miconazole.
[8] The contents of phosphatidylinositol (PI), phosphatidylethanolamine (PE) and Mahmoudabadi et al.
phosphatidylcholine (PC) decrease with validamycin A. [16] The aim of this study was to determine whether amphotericin B, nystatin and miconazole have similar effects upon the fatty acids and phospholipids of C. albicans and C. dubliniensis.
Materials and Methods
Organisms and preparation of the inoculum Candida albicans and C. dubliniensis were obtained from the patients of Dental Hospital, the University of Manchester. Isolates were confirmed as C. albicans (C4, C70) and C. dubliniensis (C1) by production of yellow-green to blue-green polar lipids data were obtained from cells growing on the next serial dilution (0.125 mg/l). Carboxylate anion profiles of both tested Candida grown on nystatin showed that C 18:1 was the major fatty acid in spectra. When C. albicans grew on SLM + nystatin the biosynthesis of m/z 297(C 19:0 ) in C. albicans (C70) and 227(C 14:0 ) in C. albicans (C4) were inhibited, whereas the contents of m/z 281(C 18:1 ) and 279(C 18:2 ) were increased in both isolates. [ Table 1 ] The content of phosphatidic acid (PA) in C. albicans (C70) was proportionately decreased compared to control from 36.7% to 24.7%. [ Table 2 ] Other phospholipids, such as PE and phosphatidylglycerol (PG), were considerably increased from 23.1% to 35.3% and 20.6% to 36.1%, colonies on CHROMagar Candida, germ tube tests on horse respectively. serum, and by production of chlamydoconidia on cornmeal [17] Briefly, yeast isolates were sub-cultured a combined amount of 80.9% of total acid anions in control to on SDA and incubated at 37 o C for 24 h. Yeast cells were only 41.3%, on the other hand, 283(C collected in 2 ml of sterile phosphate buffer solution (PBS)
1.4% in controls to 19.9%. Amphotericin B inhibited the with sterile cotton wool swabs to prepare a suspension. The biosynthesis of m/z 239(C 15:1 ), 241(C suspension was adjusted to 70% T by a spectrophotometer 297(C 19:0 ) in C. albicans (C70) and m/z 297(C (Pye Unicam) set at 530 nm, which was expected to result in a in C. albicans (C4).
[ Table 1 ] PA and PE were decreased in suspension containing about 1 X 10 6 cfu/ml. both C. albicans isolates, whereas PG decreased from 20.6% in control to 8.6% in C. albicans (C70) and increased in C. albicans (C4).
[ Table 2 ] Sixty-four mg of amphotericin B (Sigma, Poole, Dorset, UK),
Miconazole: The MIC of miconazole for both tested nystatin (Sigma) and miconazole (Sigma) were separately C. albicans (C4, C70) was 2 mg/l and polar lipids were obtained dissolved in 50 ml of dimethyl sulphoxide (Sigma) at from growing on the next serial concentration (1 mg/l). The 1280 mg/l. The solutions were left at room temperature for carboxylate anions detected after-growth of C. albicans (C70) 30 min for self-sterilisation and then stored at - Table 1 ] The content of PA, PG and PE were decreased containing Sabouraud liquid medium (SLM) (Oxoid, Hampshire, compared with C. albicans (C70). The content of PA, PG and England) and inoculated with 50 µl of standardised suspension PE were considerably increased in C. albicans (C4).
[ Table 2 ] of tested yeasts. The flasks were then incubated in shaking Candida dubliniensis water bath at 37 o C for 48 h. The last flask that had growth was centrifuged and the yeast cells harvested, washed and freeze Nystatin: The MIC of nystatin for C. dubliniensis (C1) was 1 mg/l, and the polar lipids were obtained from growing on the next serial dilution (0.5 mg/l). Nystatin caused the proportion Lipid extraction and analysis USA). Polar lipids were extracted from freeze-dried cells with chloroform-methanol (1:2, v/v) and analysed by fast atom bombardment mass spectrometry (FAB MS) in negative-ion mode with a Concept IS mass spectrometer (Kratos, Manchester, UK). All experiments were repeated three times. Fatty acids were presented as low mass ions (m/z 200-300), while phospholipid analogue anions were seen as high mass anions (m/z 500-1000). The 10 most abundant anion peaks per isolate observed in the mass spectra were selected for data analysis. Results were entered into a spreadsheet (Excel) and normalised (Σ% peaks = 100).
Results

Candida albicans
Nystatin: The minimal inhibitory concentration (MIC) of nystatin for both isolates of C. albicans was 0.25 mg/l; the of m/z 253(C 16:1 ), 255(C 16:0 ), 279(C 18:2 ) and 281(C 18:1 ) to decrease, while the proportions of m/z 283(C 18:0 ) and 241(C 15:0 ) increased. The proportion of 295(C 19:1 ) was only seen in C. dubliniensis (C1) when exposed to nystatin. [ Table 1 ] The content of PE and PG generally decreased in the presence of nystatin whereas PA increased. Phosphatidylserine (PS) was found in C. dubliniensis when exposed to nystatin whereas controls had none detectable. [ Table 2 ]
Amphotericin B: In this study, the MIC of amphotericin B for C. dubliniensis (C1) was 1.0 mg/l and the polar lipids were obtained from growing on the next serial dilution of amphotericin B (0.5 mg/l). Table 1 amphotericin B, miconazole and nystatin affect both the morphology of C. albicans cells and their mechanisms of drug resistance. However, the effect of antifungals on phospholipid analogues and fatty acids of yeasts has not been examined. Our results showed that the content of polar lipids (carboxylic acids and phospholipids) was changed in Candida isolates when grown with nystatin, miconazole and amphotericin B. Koul et al., [18] have suggested that lipids are targeted by some of the anti Candida drugs. Van Den Bossche et al., [8] have suggested that this shift, to more unsaturated fatty acid, results in increased membrane fluidity. According to Niimi et al., [19] unsaturated fatty acids bind to azole (clotrimazole). Hitchcock of unsaturated fatty acids in both species increased when exposed with nystatin, whereas amphotericin B and miconazole decreased the proportion of unsaturated fatty acids.
Conclusion
It is concluded that the biosynthesis of fatty acids and phospholipids are affected by nystatin, amphotericin B and miconazole, in addition to effects on ergosterol as previously described. Also antifungals have different effects on polar lipids of different strains of C. albicans.
